PMID- 15902698 OWN - NLM STAT- MEDLINE DCOM- 20051006 LR - 20161124 IS - 0146-6615 (Print) IS - 0146-6615 (Linking) VI - 76 IP - 3 DP - 2005 Jul TI - HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma. PG - 302-10 AB - Polymorphisms of genes in the human leukocyte antigen (HLA) complex, particularly those encoding HLA-DR, have been suggested as markers of susceptibility to Kaposi's sarcoma (KS). We conducted a case-control study comparing 147 homosexual men who developed KS after infection by human immunodeficiency virus-1 (HIV-1) and human herpes virus 8 (HHV8) with 147 matched dually infected men without HIV-associated KS (HIV-KS) from the Multicenter AIDS Cohort Study. HLA-B, DRB1, DRB3, DRB4, DRB5, and DQB1 polymorphisms were examined by high-resolution DNA-based methods. Differences in distributions of genetic variants were tested by conditional logistic regression. Previously reported relationships with HLA-DRB1 alleles could not be confirmed. Instead, other associations were observed. In univariate analysis, KS was weakly associated with B*2702/5 (odds ratio (OR)=0.40, 95% confidence interval (CI)=0.18-0.91). Similar or stronger associations, positive or negative, were seen for haplotypes containing class II alleles: DRB1*1302-DQB1*0604 (OR=3.67, 95% CI=1.02-13.1), DRB4 (DR53) haplotype family members [OR=0.52, 95% CI=0.32-0.85], and DRB3 (DR52) haplotype family members (OR=1.69, 95% CI=1.07-2.67). The B*1402-DRB1*0102 haplotype, which invariably contains the V281L mutation in the 21-hydroxylase gene governing adrenal steroid biosynthesis, occurred in five cases and one control (OR=5.0, 95% CI=0.58-42.8). In a final multivariable analysis, only DRB1*1302-DQB1*0604 (OR=6.43, 95% CI=1.28-32.3, P=0.02) remained significantly associated with KS. Associations of HLA-DRB families with HIV-KS could reflect underlying immune dysregulation. The HLA B*1402-DRB1*0102 haplotype associated with increased risk of KS might represent an antigen-presenting pathway unfavorable for immune response to HHV8. Alternatively, the relationship might hold a clue to the predilection of KS for men because that haplotype harbors the mutant form of the 21-hydroxylase gene. CI - Copyright (c) 2005 Wiley-Liss, Inc. FAU - Dorak, M Tevfik AU - Dorak MT AD - Department of Epidemiology and Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294-0022, USA. FAU - Yee, Leland J AU - Yee LJ FAU - Tang, Jianming AU - Tang J FAU - Shao, Wenshuo AU - Shao W FAU - Lobashevsky, Elena S AU - Lobashevsky ES FAU - Jacobson, Lisa P AU - Jacobson LP FAU - Kaslow, Richard A AU - Kaslow RA LA - eng GR - 5-MO1-RR-00722/RR/NCRR NIH HHS/United States GR - UO1-AI-35039/AI/NIAID NIH HHS/United States GR - UO1-AI-35040/AI/NIAID NIH HHS/United States GR - UO1-AI-35041/AI/NIAID NIH HHS/United States GR - UO1-AI-35042/AI/NIAID NIH HHS/United States GR - UO1-AI-35043/AI/NIAID NIH HHS/United States GR - UO1-AI-37613/AI/NIAID NIH HHS/United States GR - UO1-AI-37984/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Med Virol JT - Journal of medical virology JID - 7705876 RN - 0 (Genetic Markers) RN - 0 (HLA-B Antigens) RN - 0 (HLA-DQ Antigens) RN - 0 (HLA-DQ beta-Chains) RN - 0 (HLA-DQbeta antigen) RN - 0 (HLA-DR Antigens) RN - 0 (HLA-DRB1 Chains) RN - EC 1.14.14.16 (Steroid 21-Hydroxylase) SB - IM MH - Case-Control Studies MH - Genetic Markers MH - Genetic Predisposition to Disease MH - Genotype MH - HIV Infections/*complications MH - HLA-B Antigens/*genetics MH - HLA-DQ Antigens/*genetics MH - HLA-DQ beta-Chains MH - HLA-DR Antigens MH - HLA-DRB1 Chains MH - Haplotypes MH - Herpesvirus 8, Human/isolation & purification MH - Homosexuality, Male MH - Humans MH - Male MH - *Polymorphism, Genetic MH - Sarcoma, Kaposi/etiology/*genetics MH - Steroid 21-Hydroxylase/genetics EDAT- 2005/05/20 09:00 MHDA- 2005/10/07 09:00 CRDT- 2005/05/20 09:00 PHST- 2005/05/20 09:00 [pubmed] PHST- 2005/10/07 09:00 [medline] PHST- 2005/05/20 09:00 [entrez] AID - 10.1002/jmv.20361 [doi] PST - ppublish SO - J Med Virol. 2005 Jul;76(3):302-10. doi: 10.1002/jmv.20361.